Products & ReviewClinical Diagnostics
VeriSeq™ NIPT Solution v2
Comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
Request Pricing
Receive your quote directly from the manufacturer.
Description
The VeriSeq NIPT Solution v2 is an in vitro diagnostic test intended for use as a screening test for the detection of genome-wide fetal genetic anomalies from maternal peripheral whole blood specimens in pregnant women of at least 10 weeks gestation. VeriSeq NIPT Solution v2 uses whole-genome sequencing to detect partial duplications and deletions for all autosomes and aneuploidy status for all chromosomes.
For In Vitro Diagnostic Use
Contact an Illumina representative for regional availability.
